ID

27542

Description

Study Part: Investigator’s Statement Follow-Up. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Mots-clés

  1. 20/11/2017 20/11/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

20 novembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Investigator’s Statement Follow-Up Ropinirole Parkinson Disease 101468/165

Investigator’s Statement Follow-Up

INVESTIGATOR’S STATEMENT
Description

INVESTIGATOR’S STATEMENT

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C1710187
Patient Number
Description

Patient Number

Type de données

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Description

Centre Number

Type de données

text

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Check all Adverse Event forms are up to date and complete
Description

Adverse Event

Type de données

boolean

Alias
UMLS CUI [1]
C0877248
Check that the Concomitant Medication form is up to date
Description

Concomitant Medication

Type de données

boolean

Alias
UMLS CUI [1]
C2347852
Check that all appropriate pages are signed (thus indicating completion) and dated
Description

consent

Type de données

boolean

Alias
UMLS CUI [1]
C1511481
Check that laboratory results are included
Description

laboratory results

Type de données

boolean

Alias
UMLS CUI [1]
C1254595
I certify that the observations and findings are recorded correctly and completely in this CRF.
Description

complete

Type de données

boolean

Alias
UMLS CUI [1]
C0205197
Investigator:
Description

Investigator

Type de données

text

Alias
UMLS CUI [1]
C2826892
Date:
Description

Date

Type de données

date

Alias
UMLS CUI [1]
C0011008

Similar models

Investigator’s Statement Follow-Up

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
INVESTIGATOR’S STATEMENT
C0008961 (UMLS CUI-1)
C1710187 (UMLS CUI-2)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Adverse Event
Item
Check all Adverse Event forms are up to date and complete
boolean
C0877248 (UMLS CUI [1])
Concomitant Medication
Item
Check that the Concomitant Medication form is up to date
boolean
C2347852 (UMLS CUI [1])
consent
Item
Check that all appropriate pages are signed (thus indicating completion) and dated
boolean
C1511481 (UMLS CUI [1])
laboratory results
Item
Check that laboratory results are included
boolean
C1254595 (UMLS CUI [1])
complete
Item
I certify that the observations and findings are recorded correctly and completely in this CRF.
boolean
C0205197 (UMLS CUI [1])
Investigator
Item
Investigator:
text
C2826892 (UMLS CUI [1])
Date
Item
Date:
date
C0011008 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial